210 related articles for article (PubMed ID: 24457953)
41. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.
Ciccocioppo R; Cangemi GC; Kruzliak P; Gallia A; Betti E; Badulli C; Martinetti M; Cervio M; Pecci A; Bozzi V; Dionigi P; Visai L; Gurrado A; Alvisi C; Picone C; Monti M; Bernardo ME; Gobbi P; Corazza GR
Stem Cell Res Ther; 2015 Jul; 6(1):137. PubMed ID: 26206376
[TBL] [Abstract][Full Text] [Related]
42. Chondrogenic differentiation increases antidonor immune response to allogeneic mesenchymal stem cell transplantation.
Ryan AE; Lohan P; O'Flynn L; Treacy O; Chen X; Coleman C; Shaw G; Murphy M; Barry F; Griffin MD; Ritter T
Mol Ther; 2014 Mar; 22(3):655-667. PubMed ID: 24184966
[TBL] [Abstract][Full Text] [Related]
43. Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing.
Chinnadurai R; Copland IB; Garcia MA; Petersen CT; Lewis CN; Waller EK; Kirk AD; Galipeau J
Stem Cells; 2016 Sep; 34(9):2429-42. PubMed ID: 27299362
[TBL] [Abstract][Full Text] [Related]
44. Interleukin (IL)-10 induced by CD11b(+) cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts.
Kim YH; Wee YM; Choi MY; Lim DG; Kim SC; Han DJ
Mol Med; 2011; 17(7-8):697-708. PubMed ID: 21365122
[TBL] [Abstract][Full Text] [Related]
45. Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor.
Duffy MM; Pindjakova J; Hanley SA; McCarthy C; Weidhofer GA; Sweeney EM; English K; Shaw G; Murphy JM; Barry FP; Mahon BP; Belton O; Ceredig R; Griffin MD
Eur J Immunol; 2011 Oct; 41(10):2840-51. PubMed ID: 21710489
[TBL] [Abstract][Full Text] [Related]
46. In vitro dexamethasone pretreatment enhances bone formation of human mesenchymal stem cells in vivo.
Song IH; Caplan AI; Dennis JE
J Orthop Res; 2009 Jul; 27(7):916-21. PubMed ID: 19137580
[TBL] [Abstract][Full Text] [Related]
47. Human mesenchymal stromal/stem cells acquire immunostimulatory capacity upon cross-talk with natural killer cells and might improve the NK cell function of immunocompromised patients.
Cui R; Rekasi H; Hepner-Schefczyk M; Fessmann K; Petri RM; Bruderek K; Brandau S; Jäger M; Flohé SB
Stem Cell Res Ther; 2016 Jul; 7(1):88. PubMed ID: 27388156
[TBL] [Abstract][Full Text] [Related]
48. Endogenous Follistatin-like 1 guarantees the immunomodulatory properties of mesenchymal stem cells during liver fibrotic therapy.
Zheng X; Zhou X; Ma G; Yu J; Zhang M; Yang C; Hu Y; Ma S; Han Z; Ning W; Jin B; Zhou X; Wang J; Han Y
Stem Cell Res Ther; 2022 Aug; 13(1):403. PubMed ID: 35932064
[TBL] [Abstract][Full Text] [Related]
49. EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.
Nguyen TM; Arthur A; Hayball JD; Gronthos S
Stem Cells Dev; 2013 Oct; 22(20):2751-64. PubMed ID: 23711177
[TBL] [Abstract][Full Text] [Related]
50. Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells.
Kronsteiner B; Wolbank S; Peterbauer A; Hackl C; Redl H; van Griensven M; Gabriel C
Stem Cells Dev; 2011 Dec; 20(12):2115-26. PubMed ID: 21381973
[TBL] [Abstract][Full Text] [Related]
51. A novel therapeutic regimen for hepatic fibrosis using the combination of mesenchymal stem cells and baicalin.
Qiao H; Tong Y; Han H; Xu W; Ren Z; Ouyang J; Chen Y
Pharmazie; 2011 Jan; 66(1):37-43. PubMed ID: 21391433
[TBL] [Abstract][Full Text] [Related]
52. Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages.
Cho DI; Kim MR; Jeong HY; Jeong HC; Jeong MH; Yoon SH; Kim YS; Ahn Y
Exp Mol Med; 2014 Jan; 46(1):e70. PubMed ID: 24406319
[TBL] [Abstract][Full Text] [Related]
53. SOCS1 regulates the immune modulatory properties of mesenchymal stem cells by inhibiting nitric oxide production.
Zhang L; Dang RJ; Li H; Li P; Yang YM; Guo XM; Wang XY; Fang NZ; Mao N; Wen N; Jiang XX
PLoS One; 2014; 9(5):e97256. PubMed ID: 24826993
[TBL] [Abstract][Full Text] [Related]
54. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.
Zappia E; Casazza S; Pedemonte E; Benvenuto F; Bonanni I; Gerdoni E; Giunti D; Ceravolo A; Cazzanti F; Frassoni F; Mancardi G; Uccelli A
Blood; 2005 Sep; 106(5):1755-61. PubMed ID: 15905186
[TBL] [Abstract][Full Text] [Related]
55. Mesenchymal Stem Cells and Induced Bone Marrow-Derived Macrophages Synergistically Improve Liver Fibrosis in Mice.
Watanabe Y; Tsuchiya A; Seino S; Kawata Y; Kojima Y; Ikarashi S; Starkey Lewis PJ; Lu WY; Kikuta J; Kawai H; Yamagiwa S; Forbes SJ; Ishii M; Terai S
Stem Cells Transl Med; 2019 Mar; 8(3):271-284. PubMed ID: 30394698
[TBL] [Abstract][Full Text] [Related]
56. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
[TBL] [Abstract][Full Text] [Related]
57. Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells.
Yang K; Wang XQ; He YS; Lu L; Chen QJ; Liu J; Shen WF
Cardiovasc Diabetol; 2010 Oct; 9():66. PubMed ID: 20969783
[TBL] [Abstract][Full Text] [Related]
58. Interleukin 17 (IL-17)-Induced Mesenchymal Stem Cells Prolong the Survival of Allogeneic Skin Grafts.
Ma T; Wang X; Jiao Y; Wang H; Qi Y; Gong H; Zhang L; Jiang D
Ann Transplant; 2018 Aug; 23():615-621. PubMed ID: 30166501
[TBL] [Abstract][Full Text] [Related]
59. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
[TBL] [Abstract][Full Text] [Related]
60. Human Wharton's Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients.
Mrahleh MA; Matar S; Jafar H; Wehaibi S; Aslam N; Awidi A
Front Immunol; 2021; 12():732549. PubMed ID: 34650558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
